Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ingrid Mayer, MD
Vanderbilt-Ingram Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Georgia Hematology/oncology Associates, P.C.
Macon, Georgia, United States
- Jennie Stuart Medical Center
Hopkinsville, Kentucky, United States
- Purchase Cancer Group
Paducah, Kentucky, United States
- Memorial Health Care System
Chattanooga, Tennessee, United States
- the Jones Clinic - Germantown
Germantown, Tennessee, United States
- Jackson-Madison County Hospital
Jackson, Tennessee, United States
- Tennessee Cancer Specialists
Knoxville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2003
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 9 Aug 2012
- Registered enrollment
- 48
- Registry id
- NCT00611715
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.